Final report of research collaboration with Seoul National University College of Medicine testing antiviral efficacy of NOVO-NK on COVID-19.
최고관리자
0
1007
07-06
The company has obtained the results on the antiviral efficacy of NOVO-NK on COVID-19.
The experiment demonstrated that NOVO-NK treatment eliminates the human-derived COVID-19 virus in a 6-hour period. This experiment was first in the world to confirm that the COVID-19 virus can be destroyed and to provide a blueprint for successive treatment development.
Although NovoCell Bio wanted to share the results with the shareholders and interested parties promptly, due to the ongoing technology transfer deal and possibility of technology leaks, the company decided to postpone the release of specific technical details of the experiment.
At an appropriate time, the company will release the specifics of experimental results through the company’s website and various media.
NovoCell Bio prioritizes shareholders’ benefits and believes that the company’s success is shareholders’ success. Please look forward to the release of the final report of the experiment.
The experiment demonstrated that NOVO-NK treatment eliminates the human-derived COVID-19 virus in a 6-hour period. This experiment was first in the world to confirm that the COVID-19 virus can be destroyed and to provide a blueprint for successive treatment development.
Although NovoCell Bio wanted to share the results with the shareholders and interested parties promptly, due to the ongoing technology transfer deal and possibility of technology leaks, the company decided to postpone the release of specific technical details of the experiment.
At an appropriate time, the company will release the specifics of experimental results through the company’s website and various media.
NovoCell Bio prioritizes shareholders’ benefits and believes that the company’s success is shareholders’ success. Please look forward to the release of the final report of the experiment.